Allergy Immunotherapy Market Size, Share, Growth Analysis, By Treatment Type(Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy (SLIT)), By Allergy Type(Allergic Rhinitis, Asthma), By Distribution Channel(Hospital Pharmacies, Retail Pharmacies) - Industry Forecast 2024-2031

Allergy Immunotherapy Market Drivers

• Increasing allergy cases to support the growth of allergy immunotherapy market: The rising prevalence of diverse allergies and the introduction of innovative sublingual immunotherapies in developing nations are the main drivers of market expansion for allergy immunotherapy. In the United States, allergies are the sixth most common chronic illness, costing more than USD 18 billion annually, and affect more than 50 million people, according to data from the American College of Allergy, Asthma & Immunology. Food allergies are becoming more common among both children and adults worldwide. Therefore, it is anticipated that the demand for innovative immunotherapies will be aided by the growing burden of allergic illnesses.

Allergy Immunotherapy Market Restraints

• The newest technology available on the market, the allergy immunotherapy, requires routine maintenance. Due to the particular need for professional staff in the process, the cost of routine maintenance is relatively expensive. The system's operational costs will consequently rise as a result of this. This is the key cause or element that is projected to seriously hamper the global allergy immunotherapy market. Additionally, there is a need to raise knowledge about this microgrid management system across the many businesses, since this factor's ignorance of new technical breakthroughs could prove to be a barrier to the market's expansion for these systems.